Wealth Enhancement Advisory Services LLC increased its holdings in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 215.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,684 shares of the scientific and technical instruments company's stock after acquiring an additional 34,617 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Cognex were worth $1,648,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CGNX. Two Sigma Investments LP acquired a new position in Cognex during the fourth quarter worth about $1,136,000. Centaurus Financial Inc. boosted its holdings in Cognex by 16.0% in the 4th quarter. Centaurus Financial Inc. now owns 3,267 shares of the scientific and technical instruments company's stock valued at $117,000 after purchasing an additional 450 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Cognex by 7,515.1% in the 1st quarter. GAMMA Investing LLC now owns 31,679 shares of the scientific and technical instruments company's stock valued at $945,000 after purchasing an additional 31,263 shares during the last quarter. NBC Securities Inc. acquired a new position in Cognex in the 1st quarter valued at about $54,000. Finally, UMB Bank n.a. boosted its holdings in Cognex by 105.5% in the 1st quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock valued at $38,000 after purchasing an additional 657 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Cognex
In other Cognex news, EVP Sheila Marie Dipalma sold 2,000 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $45.03, for a total value of $90,060.00. Following the sale, the executive vice president directly owned 6,582 shares of the company's stock, valued at approximately $296,387.46. This represents a 23.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.60% of the company's stock.
Cognex Stock Down 0.5%
Shares of CGNX opened at $45.55 on Tuesday. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $47.52. The firm's 50 day moving average price is $42.42 and its 200 day moving average price is $34.07. The company has a market cap of $7.65 billion, a P/E ratio of 64.16 and a beta of 1.50.
Cognex (NASDAQ:CGNX - Get Free Report) last announced its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm had revenue of $249.09 million for the quarter, compared to the consensus estimate of $246.70 million. During the same period in the prior year, the firm earned $0.23 EPS. The firm's revenue for the quarter was up 4.2% on a year-over-year basis. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. Research analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current year.
Cognex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were given a $0.08 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. Cognex's dividend payout ratio is currently 45.07%.
Analyst Ratings Changes
Several equities analysts have weighed in on the stock. Robert W. Baird boosted their target price on shares of Cognex from $30.00 to $32.00 and gave the company a "neutral" rating in a report on Monday, June 16th. The Goldman Sachs Group boosted their target price on shares of Cognex from $36.00 to $40.00 and gave the company a "sell" rating in a report on Tuesday, September 16th. KeyCorp raised shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target on the stock in a research note on Friday, August 1st. JPMorgan Chase & Co. assumed coverage on shares of Cognex in a research note on Monday, September 15th. They issued a "neutral" rating and a $45.00 price target on the stock. Finally, Melius raised shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price target on the stock in a research note on Thursday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Cognex has an average rating of "Moderate Buy" and a consensus price target of $43.07.
View Our Latest Analysis on Cognex
Cognex Company Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Articles
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.